|
Match
|
Document |
Document Title |
|
|
US20110305777 |
DIMERIC IAP ANTAGONISTS
Smac mimetics that inhibit IAPs.
|
|
|
US20120201747 |
System and Method for Diagnosis and Treatment
This invention relates to a low cost rapid response diagnostic system to determine cortisol levels in patients selected as potential candidates for GCR (glucocorticoid receptor) antagonist therapy...
|
|
|
US20110287110 |
COMBINATION CANCER TREATMENT
Described herein are methods of inhibiting the proliferation of cancer cells and methods of treating cancer, by administering a combination of a copper chelator and a platinum-based chemotherapeutic.
|
|
|
US20130121912 |
MICRORNA-198 AS A TUMOR SUPPRESSOR IN PANCREATIC CANCER
A novel network of tumorigenic prognostic factors is identified that plays a critical role in advanced pancreatic cancer (PC) pathogenesis. This interactome is interconnected through a central...
|
|
|
US20120171306 |
THERAPEUTIC TREATMENT OF CANCER AND DYSPLASIA OF THE CERVIX OR VAGINA USING ESTROGEN ANTAGONISTS
A method for treatment of cervical or vaginal cancer and their associated dysplasia, including the steps of identifying a human cervical or vaginal cancer and/or dysplasia patient, administering an...
|
|
|
US20120100134 |
GENETIC VARIANTS IN ANGIOGENESIS PATHWAY ASSOCIATED WITH CLINICAL OUTCOME
The invention provides methods for determining the clinical outcomes for treatment with various treatment regimens available to cancer patients based on genotypes of the patients for genetic...
|
|
|
US20110286937 |
SYNTHETIC GLYCOLIPID-CONTAINING LIPOSOME
The present invention provides a glycolipid-containing liposome. In such a glycolipid-containing liposome, the glycolipid includes a plant ceramide portion and a sugar chain portion. The present...
|
|
|
US20110117078 |
Methods for the Treatment of Cancers
Methods for the treatment of cancers involving dysregulation of thromboxane receptor β (TP-β) are provided, including in certain aspects methods for diagnosing such cancers. Specific cancers i...
|
|
|
US20110171323 |
METHODS AND KITS TO PREDICT PROGNOSTIC AND THERAPEUTIC OUTCOME IN SMALL CELL LUNG CANCER
Disclosed herein are methods used in the identification of cancer patients likely or unlikely to respond to systemic chemotherapy, methods of treating cancer patients based upon the identification,...
|
|
|
US20120230952 |
DETECTION OF BLADDER CANCER
Provided are methods for detecting bladder cancer in a subject. In some aspects, methylation of one or more of MYO3A, CA10, NKX6-2, SOX11, DBC1, NPTX2, and/or A2BP1 in DNA sediment from a urine...
|
|
|
US20120034318 |
DIAGNOSTIC METHOD USING PALB2
The present invention provides a method for detecting mutations in the PALB2 gene in pancreatic cancer patients and in individuals having a family history of pancreatic cancer. Methods are also...
|
|
|
US20120070502 |
METHODS OF TREATING CANCER
The present invention provides methods and compositions for treating non-small-cell lung cancer (NSCLC) by administering a) a composition comprising nanoparticles that comprise paclitaxel and an...
|
|
|
US20110052672 |
TREATMENTS OF DISEASE OR DISORDERS USING NANOPARTICLES FOR FOCUSED HYPERTHERMIA TO INCREASE THERAPY EFFICACY
Methods are provided for the treatment of diseases and disorders using systematically-introduced nanoparticles to create a focused localized hyperthermia in a target area to enhance the effect of...
|
|
|
US20110171228 |
Methods and Compositions Relating to the Regulation of Apoptosis by MUC1 and BH3-Containing Proapoptotic Proteins
This invention relates to regulation of cell signaling, cell growth, and more particularly to the regulation of cancer or immune cell growth. The invention provides methods of inhibiting...
|
|
|
US20110142917 |
COMPOSITIONS AND METHODS FOR TREATMENT OF EAR DISORDERS
The present invention relates to pharmaceutical compositions useful for topical, non-invasive delivery of an oligonucleotide to the ear and to methods for the treatment of an ear disorder,...
|
|
|
US20110311651 |
CARDENOLIDES FOR THE TREATMENT OF OCULAR CANCER
The instant invention provides methods of using a class of compounds known as cardenolides in the treatment of proliferative diseases such as cancer. In particular, the instant invention provides...
|
|
|
US20120207809 |
Method and system for effecting changes in pigmented tissue
Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are...
|
|
|
US20110118528 |
Methods and Nutritional Formulations to Increase the Efficacy and Reduce the Side Effects of Cancer Treatment
The present invention relates to methods of protecting patients and sensitizing cancer cells in combination with chemotherapy and/or radiation therapy. More specifically, the invention provides...
|
|
|
US20120321552 |
Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
Screening and diagnostic reagents, kits and methods for primary and/or metastatic stomach or esophageal cancer are disclosed. Compositions for and methods of imaging and treating primary and/or...
|
|
|
US20110104050 |
Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
Screening and diagnostic reagents, kits and methods for primary and/or metastatic stomach or esophageal cancer are disclosed. Compositions for and methods of imaging and treating primary and/or...
|
|
|
US20120237502 |
METHOD FOR TREATING BREAST CANCER AND OVARIAN CANCER
The present invention relates to a method for the prevention or treatment of certain breast cancers or ovarian cancer comprising administering to a patient in need thereof of a therapeutically...
|
|
|
US20110076343 |
Multiple Myeloma Treatments
Methods for treating cancer by using compound PM00104, in particular, for treating multiple myeloma are provided.
|
|
|
US20110059074 |
Knowledge-Based Proliferation Signatures and Methods of Use
The present invention provides methods and compositions for predicting patient responses to cancer treatment using a proliferation gene signature. These methods can comprise measuring in a...
|
|
|
US20110033461 |
Combination Therapy for the Treatment of Cancer
Compositions which act synergistically to inhibit the growth of cancer cells and methods of use thereof are disclosed.
|
|
|
US20120323163 |
METHODS OF USING DUAL-EFFECT LIPOSOME IN THERAPY
The invention provides a method for treating target in need of such a treatments in a subject, comprising (a) administering a liposome containing a photosensitizer and a drug to a subject and (b)...
|
|
|
US20130122063 |
Nanotubes as Mitochondrial Uncouplers
A method of uncoupling mitochondria in a subject including administering nanotubes to the subject in a therapeutically effective amount, wherein the nanotubes are self-rectifying is provided. A...
|
|
|
US20110262560 |
Pigmented Emulsion Makeup Compositions With Gemstones
A pigmented emulsion composition comprising a water phase, an oil phase, and a plurality of gemstones in particulate form, and a method for providing a glow to the skin and ameliorating the...
|
|
|
US20120082736 |
Small-molecule TNF modulator to reduce the side effects of chemotherapy and radiotherapy
Cancer patients treated by chemotherapy and/or radiotherapy often suffer serious side effects. Currently, there is only one FDA approved and used as both a chemoprotector and a radioprotector,...
|
|
|
US20110044906 |
Methods for the Treatment, the Prognostic Assessment and the Staging of Non-Small Cell Lung Cancer
The present invention relates to methods for the treatment, the prognosis and the diagnosis of non-small cell lung cancer.
|
|
|
US20110280963 |
COMBINATION THERAPY FOR THE TREATMENT OF CANCER
The present invention provides methods of sensitizing lung cancer cells to cisplatin and inhibiting the growth of lung cancer tumors by employing a modified eIF-4E antisense oligonucleotide and...
|
|
|
US20120141603 |
METHODS AND COMPOSITIONS FOR LUNG CANCER PROGNOSIS
Disclosed herein are methods and materials for prognosing survival of lung cancer patients, the methods comprising the detection of gains and losses of minimal common regions and/or genes...
|
|
|
US20110311629 |
NON-ADHESIVE ELASTIC GELATIN MATRICES
The present invention is a substantially non-adhesive elastic gelatin matrix. The matrix is both non-adhesive to wounds, tissues and organs and is also elastic such that it is flexible. The matrix...
|
|
|
US20110097402 |
NON-ADHESIVE ELASTIC GELATIN MATRICES
The present invention is a substantially non-adhesive elastic gelatin matrix. The matrix is both non-adhesive to wounds, tissues and organs and is also elastic such that it is flexible. The matrix...
|
|
|
US20110243921 |
PREVENTION AND TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOSUS
Disclosed herein, in certain embodiments, are methods and compositions for the prevention and treatment of autoimmune disease. Further disclosed herein, in certain embodiments, are methods for the...
|
|
|
US20120015049 |
MICRORNA BIOMARKER IN CANCER
This invention provides compositions and methods for predicting and improving a chemotherapy response to treat an ovarian cancer. In one embodiment, the invention provides compositions and methods...
|
|
|
US20120282245 |
BIOMARKERS AND ASSAYS FOR THE TREATMENT OF CANCER
This invention features methods for prognosticating the efficacy of a cancer treatment comprising administration of a lymphotoxin-β receptor (LT-β-R) using TRAF3, TRAF2, and/or p53 markers, as w...
|
|
|
US20110189250 |
GREEN APPROACH IN METAL NANOPARTICLE-EMBEDDED ANTIMICROBIAL COATINGS FROM VEGETABLE OILS AND OIL-BASED MATERIALS
The present invention generally relates to a method of making nanoparticles and uses thereof. In particular, the invention relates to methods of making metal nanoparticles (MNPs). The invention...
|
|
|
US20120027723 |
TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION
The present invention relates to taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration. More particularly the invention...
|
|
|
US20110117211 |
Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to Disease of Mucosa
An immunomodulatory compound is utilized to treat mucosa disease.
|
|
|
US20130004482 |
Methods of Treating Breast Cancer with Anthracycline Therapy
The application describes methods for screening subjects with breast cancer to determine if the breast cancer will be responsive to a breast cancer therapy including an anthracycline. The...
|
|
|
US20110020470 |
METHODS AND COMPOSITIONS FOR TREATING CANCER
In one aspect the present invention provides methods for treating cancer in a mammal, including the step of administering to a mammal suffering from a cancer an amount of ebselen that is sufficient...
|
|
|
US20130089627 |
METHOD FOR TREATING A CANCER CAUSED BY CANCER STEM CELLS
This invention provides a method for treating a cancer caused by cancer stem cells in a subject in need thereof, comprising administering to the subject an effective amount of Antrodia camphorata...
|
|
|
US20110311648 |
Novel Methods for the Treatment of Cancer
Compositions and methods for the treatment of malignancy and chronic viral infection are disclosed.
|
|
|
US20110268669 |
COMPOSITION AND METHOD FOR TREATING EUSTACHIAN TUBE DYSFUNCTION
A method of treating Eustachian tube dysfunction in a person includes placing the person's body in a position substantially lying on one of the person's left or right sides. The side on which the...
|
|
|
US20120251630 |
REMISSION THERAPY OF CANCER WITH ISOFLAVONOIDS
Provided herein is a method of reducing incidences of cancer recurrence. The method involves administering to an individual in cancer remission an isoflavonoid. In specific instances, the treated...
|
|
|
US20110020334 |
METHODS FOR TREATING AND PREVENTING BRAIN TUMORS BASED ON BONE MORPHOGENETIC PROTEINS
The present invention is concerned with the therapy of neuroblastoma and related diseases. Specifically, the present invention relates to a method for treating or preventing neuroblastoma...
|
|
|
US20120087859 |
NANOCARRIER HAVING ENHANCED SKIN PERMEABILITY, CELLULAR UPTAKE AND TUMOUR DELIVERY PROPERTIES
The present invention relates to a biopolymer-modified nanocarrier in which chitosan is bound to a water-soluble biocompatible polymer that has been crosslinked via a photo-crosslinkable functional...
|
|
|
US20130011467 |
METHOD OF TREATING MALIGNANT SOLID TUMORS USING TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE)
This invention is directed to methods of treating solid tumor cancers, particularly refractory cancers by administration of two pluralities of microparticles, one comprising drug-carrying...
|
|
|
US20120269901 |
Methods and Compounds Useful to Induce Apoptosis in Cancer Cells
The present invention provides a method for treating cancer in a mammal comprising contacting the cancer cells with a compound which is a apogossypol, derivative.
|
|
|
US20110111057 |
Methods and Compounds Useful to Induce Apoptosis in Cancer Cells
The present invention provides a method for treating cancer in a mammal comprising contacting the cancer cells with a compound which is a apogossypol, derivative.
|